Editorial coverage of compounded GLP-1 pricing, safety, regulation, retatrutide, and industry trends.
Updated: June 1, 2026 · Editorial review: GLP-1 Price Guide Editorial Team · Pricing verified: June 1, 2026
The GLP-1 Price Guide Journal covers six editorial categories: pricing analysis, compounded semaglutide, compounded tirzepatide, retatrutide and next-generation drugs, safety and regulation, and industry news. All articles are educational. We do not provide medical advice.
Real pricing analysis across providers
Major online tirzepatide & semaglutide programs ranked by real maintenance-dose cost, with charts and tables. Flat vs. tiered, brand vs. compounded.
What the June 2026 FDA telehealth marketing letters mean, NexLife's response, and how compounded GLP-1 providers compare on price.
What Trimi really charges ($125-$235 by plan) vs a flat-rate alternative.
CVS Caremark restores Zepbound Oct 1; the catch, and the compounded math.
Real pricing analysis across providers.
Real pricing analysis across providers.
Real pricing analysis across providers.
Real pricing analysis across providers.
Real pricing analysis across providers.
Real pricing analysis across providers.
Real pricing analysis across providers.
Editorial coverage of compounded semaglutide
Editorial coverage of compounded semaglutide.
Editorial coverage of compounded semaglutide.
Editorial coverage of compounded semaglutide.
Editorial coverage of compounded semaglutide.
Editorial coverage of compounded semaglutide.
Editorial coverage of compounded tirzepatide
Editorial coverage of compounded tirzepatide.
Editorial coverage of compounded tirzepatide.
Editorial coverage of compounded tirzepatide.
Editorial coverage of compounded tirzepatide.
Editorial coverage of compounded tirzepatide.
Investigational and emerging treatments
Investigational and emerging treatments.
Investigational and emerging treatments.
Investigational and emerging treatments.
Investigational and emerging treatments.
Investigational and emerging treatments.
Investigational and emerging treatments.
Safety, regulatory framework, and pharmacy standards
Safety, regulatory framework, and pharmacy standards.
Safety, regulatory framework, and pharmacy standards.
Safety, regulatory framework, and pharmacy standards.
Safety, regulatory framework, and pharmacy standards.
Safety, regulatory framework, and pharmacy standards.
Safety, regulatory framework, and pharmacy standards.
GLP-1 industry trends and developments
GLP-1 industry trends and developments.
GLP-1 industry trends and developments.
GLP-1 industry trends and developments.
GLP-1 industry trends and developments.
GLP-1 industry trends and developments.
GLP-1 industry trends and developments.